0001607854-14-000001.txt : 20140513 0001607854-14-000001.hdr.sgml : 20140513 20140513110731 ACCESSION NUMBER: 0001607854-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140513 DATE AS OF CHANGE: 20140513 EFFECTIVENESS DATE: 20140513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lysosomal Therapeutics, Inc. CENTRAL INDEX KEY: 0001607854 IRS NUMBER: 454015802 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-217238 FILM NUMBER: 14835876 BUSINESS ADDRESS: STREET 1: 21 BLACKSTONE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-913-0166 MAIL ADDRESS: STREET 1: 21 BLACKSTONE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0707 D LIVE 0001607854 Lysosomal Therapeutics, Inc. 21 BLACKSTONE STREET CAMBRIDGE MA MASSACHUSETTS 02139 617-913-0166 DELAWARE None None Corporation true 2011 Cornelis Been c/o Lysosomal Therapeutics, Inc. 21 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Robert Carpenter c/o Lysosomal Therapeutics, Inc. 21 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Peter Wirth c/o Lysosomal Therapeutics, Inc. 21 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Director Henri Termeer c/o Lysosomal Therapeutics, Inc. 21 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Director Dimitri Krainc c/o Lysosomal Therapeutics, Inc. 21 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Director Pharmaceuticals Decline to Disclose 06b false 2014-04-30 false true false 0 4842033 4842033 0 false 11 0 0 0 false Lysosomal Therapeutics, Inc. /s/ Cornelis Been Cornelis Been President and CEO 2014-05-13